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Abstract Because of the beneficial effect of a trifluoromethyl group on the 5 
biological properties of bioactive compounds on the one hand and the versatile 6 
synthetic potential of β-lactams on the other hand, 4-CF3-β-lactams comprises 7 
interesting entities for the preparation of a large variety of CF3-substituted 8 
nitrogen-containing target structures with promising biological characteristics. In 9 
this review, we present an overview of different building block approach-based 10 
routes toward the synthesis of 4-(trifluoromethyl)azetidin-2-ones and the 11 
application of the “β-lactam synthon method” for the synthesis of a diverse set of 12 
(a)cyclic CF3-substituted molecules by means of ring-opening and ring-13 
transformation reactions.  14 
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Introduction 1 
The pivotal role of fluorine in medicinal chemistry is reflected by its presence in 2 
approximately 25% of the pharmaceuticals on the market and in the development 3 
pipeline. The increasing interest in fluorinated compounds is due to the favorable 4 
effect of fluorine on their pharmacological properties [1-3]. In particular, the use 5 
of fluorine-substituted molecules has been shown to increase the biological half-6 
life by impeding the oxidative metabolism, and to increase bioabsorption by 7 
lipophilic effects [4-5]. Subsequently, synthetic chemistry focused on the 8 
incorporation of one or more fluorine atoms into organic molecules has resulted 9 
in many new approaches and strategies [1, 3, 6]. An important part of these 10 
endeavors has been devoted to the introduction of a trifluoromethyl group into 11 
constrained nitrogen-ring systems, such as β-lactams or azetidin-2-ones [7-10]. In 12 
addition to their well-known significance as antibacterial agents, β-lactams have 13 
been attracting considerable interest as building blocks and valuable intermediates 14 
from a synthetic point of view as well [11]. Because of the high ring strain 15 
associated with the four-membered ring system, β-lactams represent prominent 16 
substrates susceptible to ring-opening and ring-transformation reactions en route 17 
to a variety of nitrogen-containing acyclic and heterocyclic compounds [11-12]. 18 
Given the beneficial effect of fluorine introduction, β-lactams bearing a 19 
trifluoromethyl group can be considered as interesting entities for the construction 20 
of novel targets with a diverse set of potential applications. 21 
The synthesis of trifluoromethyl-containing structures can be accomplished by 22 
either a trifluoromethylation approach or by a building block strategy (fluorinated 23 
synthon approach). However, the preparation of sensitive CF3-substituted 24 
structures is often hampered by difficulties associated with the late-stage 25 
introduction of the CF3 group (safety implications, reagent reactivity, economics) 26 
[13-24]. As an alternative, the application of CF3-containing building blocks can 27 
be pursued, thus avoiding the use of trifluoromethylating agents during the 28 
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synthesis. In that respect, the functionalization of β-lactams with a trifluoromethyl 1 
group comprises an interesting field of research and is increasingly applied to 2 
modify the biological and pharmacological properties of these compounds and 3 
their transformation products [5]. In this report, we present a short account of the 4 
main synthetic routes based on a building block approach as well as the reactivity 5 
profile of 4-CF3-azetidin-2-ones toward CF3-substituted amines and heterocyclic 6 
systems [25].  7 
 8 
Synthetic routes toward 4-(trifluoromethyl)azetidin-2-ones 9 
A summary of the main synthetic routes to 4-trifluoromethyl-β-lactams is 10 
presented in Scheme 1. 11 
Scheme 1 12 
 13 
 14 
1 Staudinger synthesis of 4-CF3-azetidin-2-ones  15 
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The classical, well-known method for the construction of a β-lactam core 1 
concerns the Staudinger synthesis through a [2+2]-ketene-imine 2 
cyclocondensation [26-30]. For instance, this strategy has been employed by 3 
Kuznetsova et al. for the synthesis of cis-4-CF3-β-lactam 4. The direct use of 4 
acetoxyketene, generated in situ from acetoxyacetyl chloride and triethylamine, 5 
with CF3-imine 1 [31] did not successfully furnish cis-4-CF3-β-lactam 4. In order 6 
to circumvent this unexpected obstacle, a short detour was proposed based on the 7 
cyclocondensation of benzyloxyketene with imine 1, followed by hydrogenolysis 8 
and O-acetylation (Scheme 2). The reaction of benzyloxyketene with imine 1 was 9 
performed in dichloromethane at 40 °C, giving rise to racemic cis-4-CF3-β-lactam 10 
2 in high yield (83%). The cis-selectivity was determined based on the 1H NMR 11 
spectrum of β-lactam 2, showing a coupling constant of 5-6 Hz (CDCl3) between 12 
the two vicinal protons at the C3 and C4 position, as opposed to trans-β-lactams 13 
(1-2 Hz, CDCl3) [26, 32]. Then, cis-β-lactam 2 was converted into cis-3-acetoxy-14 
β-lactam 4 through hydrogenolysis with Pd/C as a catalyst, followed by 15 
acetylation in a yield of 74% [5, 32-34].  16 
Scheme 2 17 
 18 
Applying an identical procedure as reported for the synthesis of cis-alcohols 3, a 19 
set of new 3-hydroxy-4-CF3-β-lactams 6 has successfully been prepared from the 20 
corresponding 3-benzyloxy-4-CF3-β-lactams 5 (R2 = Bn) (Scheme 3). Besides 3-21 
benzyloxy-4-CF3-β-lactams, 3-methoxy/phenyloxy-4-CF3-β-lactams 5 (R2 = Me, 22 
Ph) were synthesized as well. The alcohols 6 were transformed into new 3-oxo-23 
4-(trifluoromethyl)azetidin-2-ones 7 in acceptable yields (46-54%) through 24 
Albright-Onodera oxidation using P2O5/DMSO. Furthermore, 3-oxo-4-CF3-β-25 
lactams 7 were successfully converted into 3-methylene-4-CF3-β-lactams 8 in 51-26 
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72% yield through the addition of methylmagnesium bromide across the cyclic 1 
ketone, followed by alcohol activation and elimination [35-38].  2 
Scheme 3 3 
 4 
[2+2]-Cyclocondensation of a chiral imine and achiral ketene comprises a useful 5 
route toward chiral azetidin-2-ones. The reaction of chiral imine 9, prepared from 6 
trifluoroacetaldehyde hemiacetal and (S)-phenethylamine, with benzyloxyketene 7 
under classical Staudinger conditions has been reported to afford a crude mixture 8 
of cis-β-lactams 10 and 11 in 90% yield (Scheme 4), accompanied by minor 9 
amounts (5-8%) of trans-β-lactams. These cis-isomers were successfully 10 
separated by recrystalization of the crude mixture. Stereoisomer 10 was obtained 11 
in an excellent diastereomeric purity (> 99%) after recrystallization from ethanol, 12 
whereas stereoisomer 11 was isolated with a diastereomeric excess of 95% after 13 
SiO2 chromatography and recrystallization from pentane [32]. 14 
Scheme 4 15 
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 2 
2 Synthesis of 4-CF3-azetidin-2-ones via enolate-imine condensation  3 
The condensation of imine 1 with the lithium enolate of ethyl 4 
dibenzylaminoacetate, produced in situ from ethyl dibenzylaminoacetate and 5 
lithium diisopropylamide in dry THF, has been successfully performed leading to 6 
trans-4-CF3-β-lactam 12 in 69% yield (Scheme 5) [31]. In related research, Clader 7 
et al. also applied an ester-imine condensation for the preparation of 8 
trifluoromethyl-substituted β-lactam derivatives in the course of their study on 9 
new cholesterol absorption inhibitors [39].  10 
Scheme 5 11 
 12 
Furthermore, chiral 4-trifluoromethyl-substituted azetidin-2-ones can also be 13 
prepared via the enolate-imine condensation strategy making use of imines 14 
containing a chiral fragment. The treatment of optically active 15 
trifluoromethylimine 13 with lithium enolates, derived from various ester 16 
derivatives, provided the trans-configuration at the C3- and C4-position of β-17 
lactams 14 with rather high diastereoselectivity (95-99%). The high selectivity 18 
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was explained by a six-membered transition state 15 involving the imine and the 1 
enolate (Scheme 6) [40].  2 
Scheme 6 3 
 4 
 5 
3 Synthesis of 4-CF3-azetidin-2-ones via intramolecular N-acylation  6 
A convenient entry toward the construction of azetidin-2-ones comprises the 7 
cyclization of β-amino acid derivatives [12, 41]. In that respect, Robert and co-8 
workers have reported the cyclization of trifluoromethylated amino acid 9 
derivative 18 with methylmagnesium bromide, giving rise to 4-trifluoromethyl-β-10 
lactam 19 in a yield of 27% and C-silylated compound 20 as a side product 11 
(Scheme 7). Amino acid 18 was prepared in a quantitative yield by aminolysis 12 
and treatment of the corresponding unsaturated acid 17 with trimethylsilyl 13 
chloride, which had been effectively synthesized from alcohol 16 through 14 
elimination of water, followed by hydrolysis using sodium hydroxide in THF. 15 
With the desired 4-(trifluoromethyl)azetidin-2-one 19 in hand, the preparation of 16 
fluorine-containing sulfazecin analogs 21, with interesting bactericidal properties, 17 
has been investigated [42].  18 
Scheme 7 19 
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 1 
Yang and co-workers have devised a methodology to synthesize a CF3-substituted 2 
β-amino acid using the aza-Michael reaction (Scheme 8). As such, the major 3 
diastereomer (S,R)-24 was obtained in a yield of 68% upon treatment of chiral 4 
acrylamide 23 with aromatic amine 22, without solvent and catalyst. Aza-Michael 5 
adduct 24 was hydrolyzed into amino acid 25 with LiOH-H2O2 in a good yield 6 
(73%). It should be noted that analogs of chiral α-trifluoromethyl amino acid 25 7 
can also be prepared by reduction of the corresponding enamines or imines [43-8 
45]. Furthermore, β-CF3-β-amino ester 26, derived from 25, was cyclized in the 9 
presence of methylmagnesium bromide to construct enantioenriched 4-10 
trifluoromethylated β-lactam 27 in 69% yield. The absolute stereochemistry of 27 11 
was determined to be S, hence, the configuration of compound 25 was also 12 
assigned as S [43-46].  13 
Scheme 8 14 
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 1 
Furthermore, chiral β-amino esters 29 have effectively been prepared by the regio- 2 
and stereoselective nucleophilic ring-opening reaction of 1-benzyl-3-3 
trifluoromethyl-2-(ethoxycarbonyl)aziridine 28 (Scheme 9). Via Grignard-4 
mediated intramolecular cyclization, trans-β-lactams 30 were produced from the 5 
corresponding β-amino esters 29. The trans-configuration of β-lactams 30 was 6 
assigned by means of 1H NMR (JH3,H4 = 1.8 Hz). The stereochemistry of trans-β-7 
lactams 30 confirms the anti-relative configuration of β-amino esters 29 and 8 
underlines the stereoselectivity of the SN2 ring-opening reaction of trans-benzyl-9 
3-trifluoromethyl-2-(ethoxycarbonyl)aziridine 28 [47].  10 
Scheme 9 11 
  12 
 13 
4 Synthesis of 4-CF3-azetidin-2-ones via intramolecular C-alkylation  14 
Petrick and co-workers have recently published a new methodology for the 15 
preparation of 4-trifluoromethylated trans-β-lactams 34 by reaction of N-(1-16 
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chloro-2,2,2-trifluoroethyl)-4-methylbenzenesulfonamide 32 with various 1 
nonactivated aliphatic acid chlorides 33 in the presence of dimethylethylamine as 2 
a base and dichloromethane as a solvent (Scheme 10). Sulfonamide 32 was 3 
produced by the treatment of hemiaminal 31 with thionyl chloride in CH2Cl2 at 4 
40 °C. The use of chloroamine 32 in the cyclization reaction can offer a 5 
convenient alternative for the construction of trifluoromethylated β-lactams from 6 
highly moisture-sensitive trifluoromethylated imines [48].  7 
Scheme 10 8 
 9 
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5 Synthesis of 4-CF3-azetidin-2-ones via direct ring expansion of 3-CF3-11 
aziridine-2-carboxylates  12 
In analogy with the preparation of non-fluorinated azetidin-2-ones from the 13 
corresponding non-fluorinated aziridines [49-50], 3-chloro-4-CF3-azetidin-2-one 14 
36 was prepared through ring expansion of the corresponding fluorinated sodium 15 
aziridinyl carboxylate 35 with either oxalyl chloride or thionyl chloride (Scheme 16 
11). 17 
Scheme 11 18 
 19 
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The diastereoselectivities for this approach were significantly improved by 1 
considering the ring expansion of the carboxylic acid CF3-aziridine analogs 2 
instead of the sodium salt (Scheme 12). Aziridines cis-37 and trans-37 were 3 
treated with NaH and then thionyl chloride in toluene at 70 °C, resulting in the 4 
corresponding cis- and trans-β-lactams 38 in relatively good yields and excellent 5 
stereoselectivities. The relative configurations of the products were confirmed by 6 
1H NMR, pointing to coupling constants of 6 Hz (cis) and 3 Hz (trans). Continuing 7 
efforts have been devoted to synthesize a broad range of 4-CF3-azetidin-2-ones 8 
using different halogenating reagents, bases and solvents [51].  9 
Scheme 12 10 
 11 
 12 
6 Synthesis of 4-CF3-azetidin-2-ones via the Kinugasa reaction  13 
The Kinugasa reaction offers a general access toward the synthesis of differently 14 
substituted β-lactams via initial [3+2]-cycloaddition of nitrones with terminal 15 
alkynes in the presence of a Cu(I) salt and a polar solvent (acetonitrile or pyridine) 16 
[52-54]. Grée and co-workers have applied this method for the preparation of 3-17 
difluoroalkyl- and/or 3-(1-fluoroalkylidene)-β-lactams from propargylic gem-18 
difluorides [55]. Very recently, Kowalski and co-workers have presented a new 19 
application of fluorinated nitrones for the preparation of fluoroalkylated β-lactams 20 
via the Kinugasa reaction. Trifluorinated nitrones 40 were prepared by treating 21 
the corresponding hemiaminals 39, derived from fluoral, with para-22 
12 
 
toluenesulfonic acid using a Dean–Stark apparatus (Scheme 13). The isolated and 1 
purified nitrones 40 were then treated with different monosubstituted acetylenes 2 
41 under typical Kinugasa reaction conditions to form the expected 4-3 
trifluoromethyl-β-lactams 42 in good to high yields. The cis- and trans-4 
diastereoselectivity varied considerably depending on the type of substituent on 5 
the acetylene moiety (R2) used in the reaction [25].  6 
Scheme 13 7 
 8 
 9 
7 Synthesis of 4-CF3-azetidin-2-ones via the Reformatsky reaction 10 
The Reformatsky reaction of imine 43 with α-bromocarboxylic esters 44 in the 11 
presence of activated zinc dust in anhydrous toluene has been reported to furnish 12 
β-lactams 45 as the main products, accompanied by β-amino esters 46 (Scheme 13 
14) [56]. Information concerning the relative configuration of these products was 14 
not mentioned.  15 
Scheme 14 16 
 17 
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This method has been further extended toward the use of chiral 1,3-oxazolidines. 1 
The reaction of 2-trifluoromethyl-1,3-oxazolidines 47a,b and ethyl bromoacetate 2 
in the presence of zinc dust at reflux temperature in THF afforded 4-3 
(trifluoromethyl)azetidin-2-ones 48a,b in 42% yield as a 74:26 mixture of 4 
diastereoisomers (Scheme 15). This mixture was then purified by flash 5 
chromatography, giving pure (R,R)-48a. The lower stereoselectivity of this 6 
reaction as compared to results reported on nonfluorinated oxazolidines can be 7 
explained by inhibition of the oxazolidine ring opening toward imine formation 8 
as a result of the electron-withdrawing CF3 group. The major diastereomer 48a 9 
was easily converted into β-amino ester 49 by acidic ethanolysis in 80% yield 10 
[57].  11 
Scheme 15 12 
 13 
 14 
The reactivity profile of 4-CF3-azetidin-2-ones 15 
The study of 4-(trifluoromethyl)azetidin-2-ones comprises an appealing, yet 16 
rather scarcely explored research field to date. In general, 4-17 
(trifluoromethyl)azetidin-2-ones represent useful building blocks (β-lactam 18 
synthon method) [34] for the preparation of a broad spectrum of 19 
14 
 
trifluoromethylated N-containing compounds. In this section, both ring-opening 1 
and ring-transformation reactions will be considered. 2 
 3 
1 Ring-opening reactions of 4-CF3-azetidin-2-ones 4 
Because of the high ring strain of four-membered cyclic amides, 4-5 
(trifluoromethyl)azetidin-2-ones can be deployed as excellent building blocks for 6 
the preparation of fluorinated amino acids, dipetides and taxoids through ring-7 
opening reactions utilizing various nucleophiles (Scheme 16) [34].  8 
Scheme 16 9 
 10 
For example, the ring-opening methanolysis of 4-(trifluoromethyl)azetidin-2-11 
ones 50, catalyzed by sodium azide, has been performed in DMF at room 12 
temperature to generate the corresponding CF3-containing β-amino esters 51 in 13 
good to almost quantitative yields as single diastereomers (Scheme 17) [32, 34, 14 
15 
 
48]. Besides, ring opening-coupling reactions of these 4-CF3-β-lactams with 1 
amino esters or baccatines have been performed to afford the corresponding CF3-2 
containing dipeptides and taxoids, respectively. The synthesized fluoro-taxoids 3 
exhibited an excellent cytotoxicity against human breast cancer cell lines, 4 
especially against the drug-resistant cell line MCF7-R and LCC6-MDR [5, 33-5 
34].  6 
Scheme 17 7 
 8 
The reactivity of 4-CF3-β-lactams 5 toward ring-opening reactions has been also 9 
performed based on an indirect or a direct approach. In the indirect approach, 4-10 
CF3-β-lactams 5 were subjected to initial carbonyl removal upon treatment with 11 
AlH2Cl, providing azetidine intermediates 52. Then, azetidinium salts 53, derived 12 
from azetidines 52 through N-methylation, were subjected to ring opening by 13 
using different oxygen and nitrogen nucleophiles, furnishing a convenient entry 14 
toward a variety of α-(trifluoromethyl)amines 54 (Scheme 18). On the other hand, 15 
the direct reductive ring opening of 4-CF3-β-lactams 5 was achieved upon 16 
treatment with LiAlH4, yielding 3-aminopropan-1-ols 55. Cyclization of the latter 17 
γ-amino alcohols 55 employing formaldehyde or ethyl chloroformate afforded 18 
new 1,3-oxazinanes 56 and 1,3-oxazinan-2-ones 57, respectively [37].  19 
Scheme 18 20 
16 
 
 1 
Ring opening of 3-oxo-β-lactams 7 through C3-C4 bond fission has unexpectedly 2 
been effected in attempts to form and trap the corresponding 2,3-dioxoazetidin-4-3 
yl anions, resulting in 2-[(2,2-difluorovinyl)amino]-2-oxoacetates 58 as major 4 
products accompanied by minor amounts of 2-oxo-2-[(2,2,2-5 
trifluoroethyl)amino]acetates 59 upon treatment with alkyl halides and 6 
triethylamine in DMSO (Scheme 19). This peculiar reactivity was investigated in-7 
depth from both an experimental and a computational point of view in order to 8 
shed light on the underlying reaction mechanism [35]. This transformation was 9 
then proposed to proceed via initial alkyl halide to alcohol conversion, followed 10 
by alcohol addition across the oxo group of azetidine-2,3-diones 7 and subsequent 11 
C3-C4 bond cleavage. 12 
Scheme 19 13 
 14 
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 1 
2 Ring-transformation reactions of 4-CF3-azetidin-2-ones 2 
In addition to regioselective ring-opening reactions, 4-CF3-β-lactams have also 3 
been shown to be useful building blocks for Wittig rearrangements and alkylation. 4 
The enolates of 3-benzyloxy-4-CF3-β-lactams 60, generated with LiHMDS in 5 
THF at -78 °C, were subjected to [1,2]- and ortho-[2,3]-Wittig rearrangements, 6 
producing 3-benzyl-3-hydroxy-β-lactams 61 and 3-(2-methylphenyl)-3-hydroxy-7 
β-lactams 62, respectively (Scheme 20), which are potential precursors for the 8 
synthesis of new trifluoromethyl-substituted isoserines. Besides, α-methyl-β-9 
lactams were generated in excellent yields via quenching of the enolates of 60 10 
with methyl iodide [58].  11 
Scheme 20 12 
 13 
Furthermore, 4-CF3-β-lactams constitute convenient substrates for a classical 14 
Wittig reaction. For example, treatment of β-lactam 63 with stabilized ylides in 15 
toluene under reflux afforded alkylideneazetidines 64 in high yields (Scheme 21). 16 
Then, catalytic hydrogenation of 64 provided 4-trifluoromethylated 2-17 
alkylazetidines 65 in 78-92% yield, in which the diastereoselectivity depended on 18 
the catalyst and the solvent used. Moreover, treatment of one derivative of 64 with 19 
potassium bis(trimethylsilyl)amide at -78 °C, followed by reaction with an alkyl 20 
halide or an aldehyde, furnished 3-alkyl-substituted derivatives 66 in 68-75% 21 
yield. Hydrogenation of compounds 66 with Pd/C in ethyl acetate gave trans-2,3-22 
dialkylazetidines 67 in high yields as single isomers [59].  23 
18 
 
Scheme 21 1 
 2 
2-Hydroxy-4-CF3-β-lactams 6 have been shown to be suitable substrates for ring 3 
contraction toward the synthesis of 2-substituted 3-(trifluoromethyl)aziridines via 4 
3-chloro-4-CF3-β-lactam intermediates. In that respect, treatment of cis-3-5 
hydroxy-4-CF3-β-lactams 6 with 2 equiv of Ph3P and a small amount of NaHCO3 6 
catalyst in CCl4 afforded trans-3-chloro-4-CF3-β-lactams 66 (Scheme 22). The 7 
ring closure of γ-amino alcohols 67, derived from the LiAlH4-mediated reductive 8 
ring opening of chlorides 66, provided 3-trifluoromethylated aziridines 68 in 27-9 
61% yield upon treatment with 0.8-1 equiv of tBuOK. On the other hand, 10 
treatment of chlorides 66 with 2 equiv of KOH in methanol under reflux for 20 11 
min afforded the corresponding aziridine-2-carboxylates 69 in 25-73% yield. 12 
Besides, 3-chloro-β-lactams 66 have been shown to be versatile precursors for the 13 
construction a variety of novel chrorinated CF3-containing aminopropane 14 
derivatives, 1,3-oxazinanes, 1,3-oxazinan-2-ones as well [36].  15 
Furthermore, alcohols 6 proved to be suitable substrates for the synthesis of novel 16 
3-[2,2,2-trifluoro-1-(arylamino)ethyl]-1,4-dioxan-2-ones 72 in high yields via 17 
intramolecular cyclization of 3-(2-hydroxyethoxy)-β-lactam intermediates 71 18 
upon treatment with an excess of K2CO3 (Scheme 22). The 3-(2-hydroxyethoxy)-19 
19 
 
β-lactams 71 were prepared from allyloxyderivatives 70 through an 1 
ozonolysis/reduction sequence [36].  2 
Scheme 22 3 
 4 
The presence of an exocyclic carbon-carbon double bond as part of a constrained 5 
α,β-unsaturated amide fragment in 3-methylene-4-(trifluoromethyl)azetidin-2-6 
ones 8 allows for a multilateral application. In particular, the Michael addition of 7 
nitrogen and sulfur nucleophiles onto 4-CF3-β-lactams 8 furnished the 8 
corresponding 3-aminomethyl-4-(trifluoromethyl)azetidin-2-ones 73 and 3-9 
phenylthiomethyl-4-(trifluoromethyl)azetidin-2-ones 74, respectively (Scheme 10 
23). The deployment of 4-CF3-β-lactams 8 to undergo (electrophilic) additions led 11 
to 3-methyl-4-(trifluoromethyl)azetidin-2-ones 75 and 3-bromo-3-bromomethyl-12 
4-(trifluoromethyl)azetidin-2-ones 76. Furthermore, 4-CF3-β-lactams 8 were 13 
shown to be susceptible to cycloaddition reactions. In particular, treatment of 3-14 
methylene-β-lactams 8 with either N-phenyl- or N-tert-butyl-α-phenylnitrone 15 
afforded a convenient entry to 3-trifluoromethyl-5-oxa-2,6-diazaspiro[3.4]octan-16 
1-ones 77. 3-Trifluoromethyl-5,7-dioxa-2-azaspiro[3.4]octane-1,6-diones 78 17 
20 
 
were prepared upon treatment of the corresponding diols, derived from the OsO4-1 
mediated oxidation of 3-methylene-β-lactams 8, with triphosgene [38]. 2 
Scheme 23 3 
 4 
 5 
Conclusion 6 
In conclusion, the study of 4-(trifluoromethyl)azetidin-2-ones comprises an 7 
interesting, yet hardly explored field in terms of both synthesis and reactivity. The 8 
most important synthetic routes toward these compounds are based on [2+2]-9 
ketene-imine cyclocondensations (Staudinger synthesis), enolate-imine 10 
cyclocondensations, intramolecular N-acylations, intramolecular C-alkylations, 11 
ring expansions of aziridines, the Kinugasa reaction and the Reformatsky 12 
reaction. Moreover, the reactivity of 4-(trifluoromethyl)azetidin-2-ones has 13 
received little attention toward ring-opening reactions, although they provide an 14 
effective approach for the preparation of e.g. fluorinated amino acids, dipeptides, 15 
21 
 
taxoids and aminopropanes. In addition, these compounds have shown to be 1 
powerful substrates for a Wittig reaction, Wittig rearrangements, alkylation 2 
reactions, ring-rearrangement reactions, Michael additions, electrophilic 3 
additions and cycloadditions en route to a broad variety of CF3-substituted 4 
aziridines, dioxan-2-ones as well as stereodefined mono- and spirocyclic β-5 
lactams. In light of the increasing demand for new CF3-substituted nitrogen 6 
compounds from a medicinal viewpoint, 4-CF3-β-lactams can indeed be 7 
considered as very promising structures for further elaboration, and many more 8 
interesting new applications are to be expected in that respect in the near future. 9 
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